4
Changes in Ownership
Jasper Therapeutics, Inc. Filed Acc 0001213900-23-088896
Director bought 30,000 shares at an average $0.61 ($18,240)
From the SEC's structured data for this filing
Trades in this filing
WIGGANS THOMAS G · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-11-16 | Purchase : show line 1 in the form | +10,000 | $0.60 | $5,965 | 10,000 | D |
| 2023-11-17 | Purchase : show line 2 in the form | +10,000 | $0.60 | $5,966 | 20,000 | D |
| 2023-11-20 | Purchase : show line 3 in the form | +10,000 | $0.63 | $6,309 | 30,000 | D |
| Open-market purchases · 30,000 sh · avg $0.61 · $18,240 | ||||||
Loading xslF345X05/ownership.xml…